Brief: Biora Therapeutics Inc Says On April 4, Received Formal Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
07/04/2023 22:35
April 7 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS INC - ON APRIL 4, RECEIVED FORMAL
NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Source text for Eikon: ID:
Further company coverage: BIOR.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules